Sweden’s Innovation Agency (Vinnova) has granted Reccan 3 M SEK

Vinnova has decided to grant Reccan 3 M SEK within the call "Swelife and Medtech4Health - Collaborative project for better health in the autumn of 2021” for the development of a diagnostic test for pancreatic cancer.

Swelife and Medtech4Health are the enabler and player behind the financing together with Vinnova.

Swelife is a strategic innovation programme, funded by the Swedish Government via the Swedish innovation agency, Vinnova, and by the programme’s partners. Wesupport collaboration within academia, industry and healthcare, with the goal to strengthen Life Science in Sweden and to improve public health.

Medtech4Health strive to increase the number and quality of new innovative products and services within medtech. In collaboration with patients, healthcare, academia and business, we contribute to increasing value for people affected by disease in their everyday lives. Medtech4Health is funded by the Swedish government through the innovation authority Vinnova and by the programme’s partners

---